For example, mice lacking AMPKα1 in T cells exhibit accelerated tumor growth [39], whereas treatment with metformin [31,40]; an indirect activator of AMPK has been shown to enhance CD8+ T cell infiltration and promote tumor rejection, particularly when used in combination with PD-1 checkpoint blockade. Here, PRKAB1 is linked to neoplasm.